Primmune Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Primmune Therapeutics's estimated annual revenue is currently $775k per year.
- Primmune Therapeutics's estimated revenue per employee is $77,500
- Primmune Therapeutics's total funding is $48.3M.
Employee Data
- Primmune Therapeutics has 10 Employees.
- Primmune Therapeutics grew their employee count by -17% last year.
Primmune Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Medical Officer | Reveal Email/Phone |
2 | SVP Global Manufacturing | Reveal Email/Phone |
3 | VP Medicinal Chemistry/CoFounder | Reveal Email/Phone |
4 | SVP Global Manufacturing | Reveal Email/Phone |
5 | Chief Commercial Officer | Reveal Email/Phone |
6 | Chief Business Officer and Co-founder | Reveal Email/Phone |
7 | Chief Operating Officer | Reveal Email/Phone |
8 | Executive Assistant | Reveal Email/Phone |
9 | Chairman/President/CEO | Reveal Email/Phone |
10 | SVP/R&D/CSO/Co-founder/Director | Reveal Email/Phone |
Primmune Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Primmune Therapeutics?
Primmune Therapeutics is developing an orally administered TLR7 agonist to stimulate innate immunity in cancer immunotherapy. Our goal is to improve the response rate of patients to current and future immunotherapy medicines.
keywords:N/A
$48.3M
Total Funding
10
Number of Employees
$775k
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Primmune Therapeutics News
2022-03-30 - Primmune Therapeutics Presents Data from Phase 1 Study ...
SAN DIEGO--(BUSINESS WIRE)--Primmune Therapeutics, a biotech company harnessing the power of the innate immune system to treat solid tumors in...
2022-03-22 - Primmune Therapeutics to Participate in the 32nd Annual ...
Primmune Therapeutics is harnessing the power of the innate immune system to develop small molecule, orally administered toll-like receptor...
Other Companies in San Diego
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.9M | 10 | N/A | N/A |
#2 | $0.9M | 10 | N/A | N/A |
#3 | $2.5M | 10 | 0% | N/A |
#4 | $0.9M | 10 | 400% | N/A |
#5 | $0.6M | 10 | -62% | N/A |